Acusphere, Inc. · Lexington, MA United States (Pink Sheets: ACUS)
| 99 Hayden Avenue, Suite 385 | Phone: 617-648-8800 |
| Lexington, MA | Fax: 978-863-9993 |
| 02421 | |
| United States | 
Map This Company |
Acusphere, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Acusphere micromanages its products, but then how else would you handle microparticles? The company uses a proprietary technology to create porous microparticles smaller than red blood cells to develop cardiovascular drugs for the detection of coronary artery disease. The company is seeking marketing approval for lead injectable candidate Imagify, an injectable drug designed to identify coronary artery disease. Additional candidates in Acusphere's pipeline included treatments for acute pain (AI-525), cancer (AI-850), and asthma (AI-128). However, the company sold AI-525 and AI-850 to
Acusphere, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Pink Sheets: ACUS Headquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 77 |
Executives
12 executives listed for Acusphere, Inc.'s Lexington, MA location.
| Chairman and President | Sherri Oberg | |
|---|---|---|
| SVP Regulatory Affairs and Operations | Michael Slater |